CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The SCALPEL project aims to enhance cancer treatment by combining photodynamic therapy and immunotherapy. It focuses on marking sub-lethally damaged cancer cells with antibodies, enabling the immune system to target and eliminate these cells, potentially reducing cancer recurrence and metastasis.
Cancer ranks as a major cause of death, with 3.4 million new incidences in 2020 in Europe.
The current cancer standards of care include surgery, chemotherapy, radiotherapy and, as of late, immunotherapy, none of which have met their expected therapeutic outcome yet.
Photomedical treatments like photodynamic therapy of cancer (PDT) and Photochemical Internalisation (PCI) show great promise as effective anticancer treatments.
Both are, however, limited by the cancer cells left behind, causing canc…
OSLO UNIVERSITETSSYKEHUS HF
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Greece, Athina
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, LONGVIC
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
France, Villejuif
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
